Literature DB >> 1343884

Immunological profiles of patients from endemic areas infected with Schistosoma mansoni.

G Gazzinelli1, I R Viana, L M Bahia-Oliveira, A M Silveira, C C Queiroz, O dos S Carvalho, C L Massara, L A Fraga, D G Colley, R Correa-Oliveira.   

Abstract

Crude extracts of eggs (SEA) adult worms (SWAP) or cercariae (Cerc) have been used to stimulate Peripheral Blood Mononuclear cells (PBMC) and have provided rather distinct profiles of responses in different types of patients. In general it is clear that patients with early infections respond strongly to SEA while response to SWAP are develop more slowly. As infection progresses into the more chronic phases, a general pattern is seen which leads to lower anti-SEA proliferative responses in the face of higher responses to SWAP and variable anti-cerc responsiveness. Cured not re-exposed patients express very high levels of anti-SEA proliferation. It has recently been seen that those individuals who live in endemic areas and have continued water contact, but are repeatedly stool-negative (who are presumed to have self-cured or be putatively resistant; endemic normals) are strongly responsive to antigenic extracts, particularly to SEA. Furthermore, our results show that endemic normal individuals have significantly higher IFN gamma production upon PBMC stimulation with schistosome antigens than infected individuals. With the emergence of more studies it is becoming apparent that both the intensity and the prevalence of a given area may influence or shape the general responsiveness of the population under study.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1343884     DOI: 10.1590/s0074-02761992000800020

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  5 in total

1.  Production of interferon-gamma by natural killer cells and aging in chronic human schistosomiasis.

Authors:  E Speziali; J Bethony; O Martins-Filho; L A O Fraga; D S Lemos; L J Souza; R Correa-Oliveira; A M C Faria
Journal:  Mediators Inflamm       Date:  2004-12       Impact factor: 4.711

2.  Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens.

Authors:  Marwa H El-Faham; Maha M Eissa; Joseph E Igetei; Eglal I Amer; Susan Liddell; Mervat Z El-Azzouni; Michael J Doenhoff
Journal:  PLoS Negl Trop Dis       Date:  2017-08-25

3.  Evaluation of schistosoma mansoni morbidity one year after praziquantel treatment in rhino cAMP and obongi in west nile, Uganda.

Authors:  E I Odongo-Aginya; T L Lakwo; Med Ekkehard Doehring
Journal:  Afr J Infect Dis       Date:  2010

4.  Serological screening of the Schistosoma mansoni adult worm proteome.

Authors:  Fernanda Ludolf; Paola R Patrocínio; Rodrigo Corrêa-Oliveira; Andréa Gazzinelli; Franco H Falcone; André Teixeira-Ferreira; Jonas Perales; Guilherme C Oliveira; Rosiane A Silva-Pereira
Journal:  PLoS Negl Trop Dis       Date:  2014-03-20

5.  Is arachidonic acid an endoschistosomicide?

Authors:  Violette Said Hanna; Azza Gawish; Marwa Abou El-Dahab; Hatem Tallima; Rashika El Ridi
Journal:  J Adv Res       Date:  2018-01-10       Impact factor: 10.479

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.